Targovax is invited to present at upcoming investor and industry conferences
Oslo, Norway, 28 November 2018 - Targovax ASA (OSE: TRVX), a clinical stage biotechnology company developing immune activators to target hard-to-treat solid tumors, announces that members of its senior management will present at the following life sciences and investor conferences:Date: 29 November 2018 Venue: Nordic-American Life Science Conference, NYC, US Keynote panel: The Allure and Challenges of Nordic Healthcare Acquisitions and Partnerships Time: 12:30 PM ESTPresentation: Time: 3:00 PM EST Presenter: Torbjørn Furuseth, CFO Date: 5